Drug Withdrawals in the United States: A Systematic Review of the Evidence and Analysis of Trends

被引:49
作者
Issa, Amalia M. [1 ]
Phillips, Kathryn A. [2 ,3 ]
Van Bebber, Stephanie [2 ,3 ]
Nidamarthy, Hima G. [1 ]
Lasser, Karen E. [4 ,5 ]
Haas, Jennifer S. [6 ,7 ]
Alldredge, Brian K. [8 ,9 ]
Wachter, Robert M. [10 ]
Bates, David W. [6 ,7 ]
机构
[1] Univ Houston, Program Personalized Med & Targeted Therapeut, 300 Technol Bldg, Houston, TX 77204 USA
[2] Univ Calif San Francisco, Inst Hlth Policy Studies, Sch Pharm, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA
[4] Cambridge Hosp, Dept Med, Cambridge, MA 02139 USA
[5] Harvard Med Sch, Cambridge, MA 02139 USA
[6] Brigham & Womens Hosp, Dept Gen Internal Med, Boston, MA 02115 USA
[7] Harvard Med Sch, Boston, MA 02115 USA
[8] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA
[9] Univ Calif San Francisco, Sch Pharm, Sch Med, Dept Neurol, San Francisco, CA 94143 USA
[10] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
关键词
Prescription drug withdrawals; drug safety; evidence base; policy implications; pharmacoepidemiology; drug surveillance;
D O I
10.2174/157488607781668855
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There have been a number of highly publicized safety-based drug withdrawals in the United States in recent years. We conducted a review of drugs withdrawn since 1993 and examined trends in drug withdrawals. Our objective was to determine the frequency and characteristics of withdrawn drugs and trends since 1993, and to discuss the implications of the findings. We found that a mean of 1.5 drugs per year have been withdrawn since 1993, and that the number of withdrawals has not increased over time. However, some recent drug withdrawals have impacted large numbers of people. The rate of withdrawals alone is not an adequate measure of the status of drug safety in the US, and there is a serious dearth of data that can be used to examine the impact of drug withdrawals. Although drug withdrawals are an important issue to address, drug safety policies need to be developed within the broader context of drug safety and effectiveness. A comprehensive approach will be needed to address the improvement of drug safety. We propose improvements to the evidence base to increase drug safety and assess how new scientific evidence can be incorporated into drug safety efforts.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 71 条
[1]  
[Anonymous], 2005, METHODIST HOSP HLTH
[2]  
[Anonymous], 1993, PHYS DESK REFERENCE
[3]   FDA standards - Good enough for government work? [J].
Avorn, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10) :969-972
[4]   DRUG SAFETY DISCONTINUATIONS IN THE UNITED-KINGDOM, THE UNITED-STATES, AND SPAIN FROM 1974 THROUGH 1993 - A REGULATORY PERSPECTIVE [J].
BAKKE, OM ;
MANOCCHIA, M ;
DEABAJO, F ;
KAITIN, KI ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :108-117
[5]   Drugs and adverse drug reactions - How worried should we be? [J].
Bates, DW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15) :1216-1217
[6]   Policy and the future of adverse event detection using information technology [J].
Bates, DW ;
Evans, RS ;
Murff, H ;
Stetson, PD ;
Pizziferri, L ;
Hripcsak, G .
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2003, 10 (02) :226-228
[7]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[8]   Industry funding of the FDA: Effects of PDUFA on approval times and withdrawal rates [J].
Berndt, ER ;
Gottschalk, AHB ;
Philipson, TJ ;
Strobeck, MW .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (07) :545-554
[9]   National surveillance of emergency department visits for outpatient adverse drug events [J].
Budnitz, Daniel S. ;
Pollock, Daniel A. ;
Weidenbach, Kelly N. ;
Mendelsohn, Aaron B. ;
Schroeder, Thomas J. ;
Annest, Joseph L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (15) :1858-1866
[10]   Computerized surveillance of adverse drug events in hospital patients (Reprinted from JAMA, vol 266, pg 2847-51, 1991) [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Burke, JP .
QUALITY & SAFETY IN HEALTH CARE, 2005, 14 (03) :221-225